Follistatin 315
Peptide therapy: benefits, side effects, cost and protocols
Follistatin 315 is a specific isoform of follistatin that is membrane-bound and acts primarily in a localized, autocrine/paracrine manner. It inhibits myostatin and activin locally in muscle tissue, making it of interest for targeted muscle growth applications.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
- Evidence
- Emerging Evidence
Mechanism
How Follistatin 315 works
Binds activin and myostatin locally within muscle tissue due to heparin-binding domain, providing targeted inhibition rather than systemic effects.
Evidence
Key studies
40 papers on PubMed / 22 human trials
- 01
Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles
- 02
Fujiwara T, Sidis Y, Welt C et al
J Clin Endocrinol Metab
- 03
Inhibin subunit mRNA increases with follicle maturity; polycystic ovary syndrome shows reduced inhibin alpha subunit levels
- 04
Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice
- 05
Canali S, Core AB, Zumbrennen-Bullough KB et al
Endocrinology / Animal
- 06
Activin B stimulates hepcidin via SMAD1/5/8 signaling; follistatin-315 blunts hepcidin induction during inflammation
- 07
An engineered human follistatin variant: insights into the pharmacokinetic and pharmocodynamic relationships of a novel molecule with broad therapeutic potential
- 08
Datta-Mannan A, Yaden B, Krishnan V et al
J Pharmacol Exp Ther / Phase 1
- 09
Engineered follistatin-Fc fusion showed 100-fold improvement in half-life and robust dose-dependent effects in muscle atrophy models
- 10
Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice
FAQ
Follistatin 315 questions
What is FOLLISTATIN 315?
Follistatin 315 is a tissue-bound isoform of follistatin with more localized myostatin-blocking activity compared to the circulating Follistatin 344 variant.
How does FOLLISTATIN 315 work?
Binds activin and myostatin locally within muscle tissue due to heparin-binding domain, providing targeted inhibition rather than systemic effects.
Is FOLLISTATIN 315 legal to buy?
FOLLISTATIN 315 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy FOLLISTATIN 315?
FOLLISTATIN 315 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does FOLLISTATIN 315 belong to?
FOLLISTATIN 315 is primarily classified as a growth hormone secretion peptide. Peptides that stimulate or support growth hormone release, including GHRH analogs, GHRPs, and direct GH compounds for muscle, recovery, and anti-aging research.
What are the research benefits of FOLLISTATIN 315?
FOLLISTATIN 315 has been studied for: Localized myostatin inhibition, Targeted muscle support, Lean mass preservation. Tissue-bound follistatin isoform; more targeted than FS-344.
News
Follistatin 315 in the news
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Follistatin 315?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.